Mark Heibel, MD
Dermatology · Lincoln, NENPI 1417946484
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,461 of the $2,100 with a category attached, or 69.6%. 10 manufacturers reported payments, led by AbbVie at 41.8% of the total. That places this record below the midpoint for dermatology clinicians in NE, where the typical reported total is $2,089.
Across 97 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$878
- Johnson & Johnson$825
- Janssen Scientific Affairs, LLC$254
- Lilly USA, LLC$27
- E.r. Squibb & Sons, L.L.C.$25
- Sanofi$21
- plus $72 from 4 others
What the payments were for
- Food & beverage$1,46170%
- Education$63930%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $878 |
| Johnson & Johnson | 28 | $825 |
| Janssen Scientific Affairs, LLC | 3 | $254 |
| Lilly USA, LLC | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Sanofi | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Organon | 3 | $17 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$105
How this compares
$2,100 in reported general payments places this provider in the 50th percentile of 68 dermatology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 12 | $261,289 |
| EnbrelEtanercept | 13 | $94,897 |
| Clobetasol Propionate | 374 | $19,801 |
| Doxycycline Hyclate | 346 | $8,319 |
| MethotrexateMethotrexate Sodium | 134 | $4,707 |
| Metronidazole | 55 | $4,504 |
| Hydroxychloroquine Sulfate | 86 | $2,869 |
| Minocycline Hcl | 231 | $2,507 |
| Fluticasone Propionate | 112 | $2,371 |
| Fluorouracil | 28 | $2,053 |
| Triamcinolone Acetonide | 172 | $1,830 |
| Halobetasol Propionate | 33 | $1,769 |
| Dapsone | 24 | $1,354 |
| Nystatin | 87 | $1,296 |
| Betamethasone Dipropionate | 17 | $1,281 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Lincoln
- Casey BowenLincoln$51K
- Rex LargenLincoln$26K
- Lauren StephensLincoln$18K
- Gina WeirLincoln$10K
- Margaret SuttonLincoln$7K
- Nicolette NetzLincoln$7K
- Rodney BaslerLincoln$5K
- Brian HerbinLincoln$2K
- Tyler EvansLincoln$2K
- Rudolf StrnotLincoln$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.